United Therapeutics | UTHR - Cost Of Sales


United Therapeutics reported $99.5M in Cost of Sales for its fiscal quarter ending in June of 2026.





Cost Of Sales Change Date
Amarin USD 26.05M 1.41M Dec/2025
Ardelyx USD 4.81M 6.04M Mar/2026
Baxter International USD 1.93B 118M Jun/2026
Bayer EUR 5.23B 731M Mar/2026
BioCryst Pharmaceuticals USD 3.84M 5.68M Jun/2026
Biogen USD 945.1M 147.6M Jun/2026
BioMarin Pharmaceutical USD 276.29M 76.8M Jun/2026
Emergent BioSolutions USD 381.2M 226.1M Jun/2023
Gilead Sciences USD 1000M 445M Jun/2026
GlaxoSmithKline GBP 2.07B 192M Jun/2026
Halozyme Therapeutics USD 108.68M 67K Jun/2026
Insmed USD 69.29M 19.79M Jun/2026
Ionis Pharmaceuticals USD 2.74M 261K Jun/2026
J&J USD 8B 67M Jun/2026
Lexicon Pharmaceuticals USD 201K 191K Dec/2025
Moderna USD 93M 862M Jun/2026
Omeros USD 33.16M 18.52M Jun/2024
Pfizer USD 4.09B 498M Jun/2026
PTC Therapeutics USD 39.61M 23.31M Mar/2026
Regeneron Pharmaceuticals USD 576.5M 92.9M Jun/2026
Sangamo BioSciences 2.42M 1.11M Jun/2024
Sarepta Therapeutics USD 150.1M 40.64M Jun/2026
Teva Pharmaceutical Industries USD 1.98B 30M Jun/2026
United Therapeutics USD 99.5M 33.9M Jun/2026
Vertex Pharmaceuticals USD 489.2M 96.4M Jun/2026